22nd treatment shown to reduce risk in
May 2021, now with p = 0.00036 from 21 studies, recognized in 7 countries.
Efficacy is variant dependent.
No treatment is 100% effective. Protocols
combine treatments.
5,100+ studies for
112 treatments. c19early.org
|
risk of symptomatic case, 57.0% lower, RR 0.43, p < 0.001, treatment 483, control 482, group sizes estimated because they were not supplied.
|
risk of symptomatic case, 80.0% lower, RR 0.20, p < 0.001, treatment 150, control 149, nursing home residents, group sizes estimated because they were not supplied.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |